CNS Pharmaceuticals (NASDAQ: CNSP) , a biopharmaceutical company focused on developing treatments for brain and central nervous system cancers, will ...

In this video, Annick Desjardins, MD, professor of neurosurgery, professor of neurology and member of the Duke Cancer Institute, discusses what she is most looking forward to in the future of brain ...

Brain metastases (BMs) are a devastating complication of cancer, occurring ten times more frequently than primary brain ...

Explore the potential of monoclonal antibodies in Alzheimer’s treatment, including breakthroughs and challenges in this ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Prior studies have found microplastics in lungs, placentas and testes — but the most common spot for them may be even more ...

Microplastics are accumulating in human brains at alarming rates, with concentrations rising 50% in the past eight years.

Share on PinterestScientists are examining the link between bacteria in the mouth and neurodegenerative diseases such as dementia. Design by MNT; Photography by Henry Horenstein/Getty Images & STEVE ...

The manufacturer of AV-101, an investigational, oral nonopioid, NMDA-targeting therapy to treat neuropathic pain, announced that it has received a U.S. patent for the treatment. AV-101 (4-Cl-KYN) is ...

With the strong associations established in epidemiologic studies and a dearth of evidence on the actual mechanisms by which ...

Early dysfunction of the endothelial/blood-brain barrier (BBB) is involved in the pathogenesis of cerebral small vessel disease (SVD), which is a contributor to about 50% of dementias.

In a recent study of 35 World Trade Center first responders in the Journal of Alzheimer’s Disease, lead author Sean Clouston, ...